Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Rodriguez, R
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. [electronic resource] - Bone marrow transplantation Jun 2004 - 1123-9 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704493 doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclosporine--administration & dosage
Female
Graft Survival
Graft vs Host Disease--prevention & control
Hematologic Neoplasms--complications
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
Melphalan--administration & dosage
Middle Aged
Mycophenolic Acid--administration & dosage
Opportunistic Infections
Premedication--methods
Prospective Studies
Survival Analysis
Tissue Donors
Transplantation Conditioning--methods
Treatment Outcome
Vidarabine--administration & dosage
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. [electronic resource] - Bone marrow transplantation Jun 2004 - 1123-9 p. digital
Publication Type: Clinical Trial; Journal Article
0268-3369
10.1038/sj.bmt.1704493 doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclosporine--administration & dosage
Female
Graft Survival
Graft vs Host Disease--prevention & control
Hematologic Neoplasms--complications
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
Melphalan--administration & dosage
Middle Aged
Mycophenolic Acid--administration & dosage
Opportunistic Infections
Premedication--methods
Prospective Studies
Survival Analysis
Tissue Donors
Transplantation Conditioning--methods
Treatment Outcome
Vidarabine--administration & dosage